doi.org/10.1016/s1474-4422(19)30069-9

Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial

..., Wayne M. Clark
60
The Lancet Neurology45.50
Volume: 18, Issue: 5, Pages: 428 - 438
Published: Mar 18, 2019
Paper Fields
Paper Details
Title
Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial
DOI
doi.org/10.1016/s1474-4422(19)30069-9
Published Date
Mar 18, 2019
Journal
The Lancet Neurology
Volume
18
Issue
5
Pages
428 - 438
© 2025 Pluto Labs All rights reserved.